Skip to main content
. Author manuscript; available in PMC: 2020 Mar 24.
Published in final edited form as: Curr Cardiol Rep. 2019 Nov 25;21(12):152. doi: 10.1007/s11886-019-1238-1

Fig. 1.

Fig. 1

The sensitivity and specificity of various tests for the diagnosis of cardiac sarcoidosis in two sarcoidosis cohorts. Mehta: A sarcoidosis cohort of 62 patients from New York City, USA. Kouranos: A sarcoidosis cohort of 321 patients from Athens, Greece. Orange lines: 95% confidence intervals for specificity of various tests with the means identified; Black lines: 95% confidence intervals for sensitivity of various tests with the means identified. Cardiac sx, cardiac symptoms; ECG, electrocardiogram; Holter, 24-h ambulatory electrocardiographic monitoring; TTE, transthoracic echocardiogram; any variable, combination of all previous tests; CMR, cardiac nuclear magnetic imaging. (Reproduced from: Judson MA. Respir Med 2019, 154:155–157, with permission from Elsevier) [42]